Total: £ 56.28
Published Date: 2026-05-15 | Pages: 170 | Tables: 170 | Service & Software
The global Premarital Genetic Testing market was valued at US$ 1469 million in 2025 and is anticipated to reach US$ 2090 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Premarital genetic testing refers to a medical testing service that analyzes the genetic material of both partners before marriage or planned reproduction to assess whether they carry disease-causing gene mutations, chromosomal abnormalities, or related genetic risks that may lead to genetic diseases in their offspring. Its core purpose is to identify carrier status of recessive genetic diseases and reproductive risks in advance, thereby providing a scientific basis for marriage and childbearing decisions. When necessary, it can reduce the risk of birth defects through genetic counseling, assisted reproductive technology, or prenatal diagnosis, and is an important component of preventive medicine and reproductive health management.
The premarital genetic testing industry has continued growth potential, primarily driven by factors including increased global awareness of birth defect prevention, the promotion of eugenic policies, decreasing costs of genetic testing, and the maturity of precision medicine technologies. With the widespread adoption of NGS technology, the scope of testing has gradually expanded from single-gene diseases to chromosomal abnormalities and polygenic risk assessment, continuously improving the accuracy and coverage of testing. Meanwhile, in emerging markets with large populations such as China, India, and the Middle East, government emphasis on birth defect prevention is accelerating the popularization of this type of testing. In the future, the industry will further develop towards an integrated service model of "testing + genetic counseling + reproductive assisted decision-making", and gradually integrate into hospitals, physical examination centers and consumer-level health management platforms. There is still considerable room for improvement in market penetration.
The North American market for Premarital Genetic Testing is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Premarital Genetic Testing is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Premarital Genetic Testing in Male is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Premarital Genetic Testing include NxGen MDx, LLC, OPKO Health, Gene by Gene, Sonic Genetics, MedGenome Labs, Centogene, LSI Medience, GC Genome, Illumina, Fulgent Genetics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Premarital Genetic Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Premarital Genetic Testing. The Premarital Genetic Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Premarital Genetic Testing market comprehensively. Regional market sizes by Testing Content, by Application, by Technical Methods, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Premarital Genetic Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Testing Content, by Application, and by region.
Market Segmentation
By Company
NxGen MDx, LLC
OPKO Health
Gene by Gene
Sonic Genetics
MedGenome Labs
Centogene
LSI Medience
GC Genome
Illumina
Fulgent Genetics
Natera
Clinical Labs
Eurofins Scientific
Myriad Genetics
Thermo Fisher Scientific
Genoma Group
SRL Inc.
Seegene
Huizhi Gene
My Baby Company
Invitae
Dian Diagnostics Group
Adicon
BGI
WuXi AppTec
Novogene
Berry Genomics
Kingmed Diagnostic
Zhongyuan Concord
AmoyDx
Segment by Testing Content
Single-Gene Genetic Disease Testing
Chromosomal Structural And Numerical Abnormality Testing
Polygenic Disease Risk Assessment
Mitochondrial And Maternal Genetic Testing
Pharmacogenomics And Functional Gene Testing
Segment by Technical Methods
Gene Sequencing Testing
Microarray Testing
Karyotype Analysis
PCR Site-Directed Mutagenesis Detection
Multi-Technology Combined Testing Solutions
Segment by Service Provider
Medical Institution Testing Services
Third-Party Genetic Testing Laboratory Services
DTC Genetic Testing Services
Integrated Medical + Genetic Counseling Services
Segment by Application
Male
Female
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Testing Content, by Application, by Technical Methods, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Premarital Genetic Testing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Testing Content, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Testing Content
1.2.1 Global Premarital Genetic Testing Market Size Growth Rate by Testing Content: 2021 vs 2025 vs 2032
1.2.2 Single-Gene Genetic Disease Testing
1.2.3 Chromosomal Structural And Numerical Abnormality Testing
1.2.4 Polygenic Disease Risk Assessment
1.2.5 Mitochondrial And Maternal Genetic Testing
1.2.6 Pharmacogenomics And Functional Gene Testing
1.3 Market by Technical Methods
1.3.1 Global Premarital Genetic Testing Market Size Growth Rate by Technical Methods: 2021 vs 2025 vs 2032
1.3.2 Gene Sequencing Testing
1.3.3 Microarray Testing
1.3.4 Karyotype Analysis
1.3.5 PCR Site-Directed Mutagenesis Detection
1.3.6 Multi-Technology Combined Testing Solutions
1.4 Market by Service Provider
1.4.1 Global Premarital Genetic Testing Market Size Growth Rate by Service Provider: 2021 vs 2025 vs 2032
1.4.2 Medical Institution Testing Services
1.4.3 Third-Party Genetic Testing Laboratory Services
1.4.4 DTC Genetic Testing Services
1.4.5 Integrated Medical + Genetic Counseling Services
1.5 Market by Application
1.5.1 Global Premarital Genetic Testing Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Male
1.5.3 Female
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Premarital Genetic Testing Market Perspective (2021–2032)
2.2 Global Premarital Genetic Testing Growth Trends by Region
2.2.1 Global Premarital Genetic Testing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Premarital Genetic Testing Historic Market Size by Region (2021–2026)
2.2.3 Premarital Genetic Testing Forecasted Market Size by Region (2027–2032)
2.3 Premarital Genetic Testing Market Dynamics
2.3.1 Premarital Genetic Testing Industry Trends
2.3.2 Premarital Genetic Testing Market Drivers
2.3.3 Premarital Genetic Testing Market Challenges
2.3.4 Premarital Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Premarital Genetic Testing Players by Revenue
3.1.1 Global Top Premarital Genetic Testing Players by Revenue (2021–2026)
3.1.2 Global Premarital Genetic Testing Revenue Market Share by Players (2021–2026)
3.2 Global Top Premarital Genetic Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Premarital Genetic Testing Revenue
3.4 Global Premarital Genetic Testing Market Concentration Ratio
3.4.1 Global Premarital Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Premarital Genetic Testing Revenue in 2025
3.5 Global Key Players of Premarital Genetic Testing Head Offices and Areas Served
3.6 Global Key Players of Premarital Genetic Testing, Products and Applications
3.7 Global Key Players of Premarital Genetic Testing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Premarital Genetic Testing Breakdown Data by Testing Content
4.1 Global Premarital Genetic Testing Historic Market Size by Testing Content (2021–2026)
4.2 Global Premarital Genetic Testing Forecasted Market Size by Testing Content (2027–2032)
5 Premarital Genetic Testing Breakdown Data by Application
5.1 Global Premarital Genetic Testing Historic Market Size by Application (2021–2026)
5.2 Global Premarital Genetic Testing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Premarital Genetic Testing Market Size (2021–2032)
6.2 North America Premarital Genetic Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Premarital Genetic Testing Market Size by Country (2021–2026)
6.4 North America Premarital Genetic Testing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Premarital Genetic Testing Market Size (2021–2032)
7.2 Europe Premarital Genetic Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Premarital Genetic Testing Market Size by Country (2021–2026)
7.4 Europe Premarital Genetic Testing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Premarital Genetic Testing Market Size (2021–2032)
8.2 Asia-Pacific Premarital Genetic Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Premarital Genetic Testing Market Size by Region (2021–2026)
8.4 Asia-Pacific Premarital Genetic Testing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Premarital Genetic Testing Market Size (2021–2032)
9.2 Latin America Premarital Genetic Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Premarital Genetic Testing Market Size by Country (2021–2026)
9.4 Latin America Premarital Genetic Testing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Premarital Genetic Testing Market Size (2021–2032)
10.2 Middle East & Africa Premarital Genetic Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Premarital Genetic Testing Market Size by Country (2021–2026)
10.4 Middle East & Africa Premarital Genetic Testing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NxGen MDx, LLC
11.1.1 NxGen MDx, LLC Company Details
11.1.2 NxGen MDx, LLC Business Overview
11.1.3 NxGen MDx, LLC Premarital Genetic Testing Introduction
11.1.4 NxGen MDx, LLC Revenue in Premarital Genetic Testing Business (2021–2026)
11.1.5 NxGen MDx, LLC Recent Development
11.2 OPKO Health
11.2.1 OPKO Health Company Details
11.2.2 OPKO Health Business Overview
11.2.3 OPKO Health Premarital Genetic Testing Introduction
11.2.4 OPKO Health Revenue in Premarital Genetic Testing Business (2021–2026)
11.2.5 OPKO Health Recent Development
11.3 Gene by Gene
11.3.1 Gene by Gene Company Details
11.3.2 Gene by Gene Business Overview
11.3.3 Gene by Gene Premarital Genetic Testing Introduction
11.3.4 Gene by Gene Revenue in Premarital Genetic Testing Business (2021–2026)
11.3.5 Gene by Gene Recent Development
11.4 Sonic Genetics
11.4.1 Sonic Genetics Company Details
11.4.2 Sonic Genetics Business Overview
11.4.3 Sonic Genetics Premarital Genetic Testing Introduction
11.4.4 Sonic Genetics Revenue in Premarital Genetic Testing Business (2021–2026)
11.4.5 Sonic Genetics Recent Development
11.5 MedGenome Labs
11.5.1 MedGenome Labs Company Details
11.5.2 MedGenome Labs Business Overview
11.5.3 MedGenome Labs Premarital Genetic Testing Introduction
11.5.4 MedGenome Labs Revenue in Premarital Genetic Testing Business (2021–2026)
11.5.5 MedGenome Labs Recent Development
11.6 Centogene
11.6.1 Centogene Company Details
11.6.2 Centogene Business Overview
11.6.3 Centogene Premarital Genetic Testing Introduction
11.6.4 Centogene Revenue in Premarital Genetic Testing Business (2021–2026)
11.6.5 Centogene Recent Development
11.7 LSI Medience
11.7.1 LSI Medience Company Details
11.7.2 LSI Medience Business Overview
11.7.3 LSI Medience Premarital Genetic Testing Introduction
11.7.4 LSI Medience Revenue in Premarital Genetic Testing Business (2021–2026)
11.7.5 LSI Medience Recent Development
11.8 GC Genome
11.8.1 GC Genome Company Details
11.8.2 GC Genome Business Overview
11.8.3 GC Genome Premarital Genetic Testing Introduction
11.8.4 GC Genome Revenue in Premarital Genetic Testing Business (2021–2026)
11.8.5 GC Genome Recent Development
11.9 Illumina
11.9.1 Illumina Company Details
11.9.2 Illumina Business Overview
11.9.3 Illumina Premarital Genetic Testing Introduction
11.9.4 Illumina Revenue in Premarital Genetic Testing Business (2021–2026)
11.9.5 Illumina Recent Development
11.10 Fulgent Genetics
11.10.1 Fulgent Genetics Company Details
11.10.2 Fulgent Genetics Business Overview
11.10.3 Fulgent Genetics Premarital Genetic Testing Introduction
11.10.4 Fulgent Genetics Revenue in Premarital Genetic Testing Business (2021–2026)
11.10.5 Fulgent Genetics Recent Development
11.11 Natera
11.11.1 Natera Company Details
11.11.2 Natera Business Overview
11.11.3 Natera Premarital Genetic Testing Introduction
11.11.4 Natera Revenue in Premarital Genetic Testing Business (2021–2026)
11.11.5 Natera Recent Development
11.12 Clinical Labs
11.12.1 Clinical Labs Company Details
11.12.2 Clinical Labs Business Overview
11.12.3 Clinical Labs Premarital Genetic Testing Introduction
11.12.4 Clinical Labs Revenue in Premarital Genetic Testing Business (2021–2026)
11.12.5 Clinical Labs Recent Development
11.13 Eurofins Scientific
11.13.1 Eurofins Scientific Company Details
11.13.2 Eurofins Scientific Business Overview
11.13.3 Eurofins Scientific Premarital Genetic Testing Introduction
11.13.4 Eurofins Scientific Revenue in Premarital Genetic Testing Business (2021–2026)
11.13.5 Eurofins Scientific Recent Development
11.14 Myriad Genetics
11.14.1 Myriad Genetics Company Details
11.14.2 Myriad Genetics Business Overview
11.14.3 Myriad Genetics Premarital Genetic Testing Introduction
11.14.4 Myriad Genetics Revenue in Premarital Genetic Testing Business (2021–2026)
11.14.5 Myriad Genetics Recent Development
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Details
11.15.2 Thermo Fisher Scientific Business Overview
11.15.3 Thermo Fisher Scientific Premarital Genetic Testing Introduction
11.15.4 Thermo Fisher Scientific Revenue in Premarital Genetic Testing Business (2021–2026)
11.15.5 Thermo Fisher Scientific Recent Development
11.16 Genoma Group
11.16.1 Genoma Group Company Details
11.16.2 Genoma Group Business Overview
11.16.3 Genoma Group Premarital Genetic Testing Introduction
11.16.4 Genoma Group Revenue in Premarital Genetic Testing Business (2021–2026)
11.16.5 Genoma Group Recent Development
11.17 SRL Inc.
11.17.1 SRL Inc. Company Details
11.17.2 SRL Inc. Business Overview
11.17.3 SRL Inc. Premarital Genetic Testing Introduction
11.17.4 SRL Inc. Revenue in Premarital Genetic Testing Business (2021–2026)
11.17.5 SRL Inc. Recent Development
11.18 Seegene
11.18.1 Seegene Company Details
11.18.2 Seegene Business Overview
11.18.3 Seegene Premarital Genetic Testing Introduction
11.18.4 Seegene Revenue in Premarital Genetic Testing Business (2021–2026)
11.18.5 Seegene Recent Development
11.19 Huizhi Gene
11.19.1 Huizhi Gene Company Details
11.19.2 Huizhi Gene Business Overview
11.19.3 Huizhi Gene Premarital Genetic Testing Introduction
11.19.4 Huizhi Gene Revenue in Premarital Genetic Testing Business (2021–2026)
11.19.5 Huizhi Gene Recent Development
11.20 My Baby Company
11.20.1 My Baby Company Company Details
11.20.2 My Baby Company Business Overview
11.20.3 My Baby Company Premarital Genetic Testing Introduction
11.20.4 My Baby Company Revenue in Premarital Genetic Testing Business (2021–2026)
11.20.5 My Baby Company Recent Development
11.21 Invitae
11.21.1 Invitae Company Details
11.21.2 Invitae Business Overview
11.21.3 Invitae Premarital Genetic Testing Introduction
11.21.4 Invitae Revenue in Premarital Genetic Testing Business (2021–2026)
11.21.5 Invitae Recent Development
11.22 Dian Diagnostics Group
11.22.1 Dian Diagnostics Group Company Details
11.22.2 Dian Diagnostics Group Business Overview
11.22.3 Dian Diagnostics Group Premarital Genetic Testing Introduction
11.22.4 Dian Diagnostics Group Revenue in Premarital Genetic Testing Business (2021–2026)
11.22.5 Dian Diagnostics Group Recent Development
11.23 Adicon
11.23.1 Adicon Company Details
11.23.2 Adicon Business Overview
11.23.3 Adicon Premarital Genetic Testing Introduction
11.23.4 Adicon Revenue in Premarital Genetic Testing Business (2021–2026)
11.23.5 Adicon Recent Development
11.24 BGI
11.24.1 BGI Company Details
11.24.2 BGI Business Overview
11.24.3 BGI Premarital Genetic Testing Introduction
11.24.4 BGI Revenue in Premarital Genetic Testing Business (2021–2026)
11.24.5 BGI Recent Development
11.25 WuXi AppTec
11.25.1 WuXi AppTec Company Details
11.25.2 WuXi AppTec Business Overview
11.25.3 WuXi AppTec Premarital Genetic Testing Introduction
11.25.4 WuXi AppTec Revenue in Premarital Genetic Testing Business (2021–2026)
11.25.5 WuXi AppTec Recent Development
11.26 Novogene
11.26.1 Novogene Company Details
11.26.2 Novogene Business Overview
11.26.3 Novogene Premarital Genetic Testing Introduction
11.26.4 Novogene Revenue in Premarital Genetic Testing Business (2021–2026)
11.26.5 Novogene Recent Development
11.27 Berry Genomics
11.27.1 Berry Genomics Company Details
11.27.2 Berry Genomics Business Overview
11.27.3 Berry Genomics Premarital Genetic Testing Introduction
11.27.4 Berry Genomics Revenue in Premarital Genetic Testing Business (2021–2026)
11.27.5 Berry Genomics Recent Development
11.28 Kingmed Diagnostic
11.28.1 Kingmed Diagnostic Company Details
11.28.2 Kingmed Diagnostic Business Overview
11.28.3 Kingmed Diagnostic Premarital Genetic Testing Introduction
11.28.4 Kingmed Diagnostic Revenue in Premarital Genetic Testing Business (2021–2026)
11.28.5 Kingmed Diagnostic Recent Development
11.29 Zhongyuan Concord
11.29.1 Zhongyuan Concord Company Details
11.29.2 Zhongyuan Concord Business Overview
11.29.3 Zhongyuan Concord Premarital Genetic Testing Introduction
11.29.4 Zhongyuan Concord Revenue in Premarital Genetic Testing Business (2021–2026)
11.29.5 Zhongyuan Concord Recent Development
11.30 AmoyDx
11.30.1 AmoyDx Company Details
11.30.2 AmoyDx Business Overview
11.30.3 AmoyDx Premarital Genetic Testing Introduction
11.30.4 AmoyDx Revenue in Premarital Genetic Testing Business (2021–2026)
11.30.5 AmoyDx Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Premarital Genetic Testing Market Size Growth Rate by Testing Content (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Single-Gene Genetic Disease Testing
Table 3. Key Players of Chromosomal Structural And Numerical Abnormality Testing
Table 4. Key Players of Polygenic Disease Risk Assessment
Table 5. Key Players of Mitochondrial And Maternal Genetic Testing
Table 6. Key Players of Pharmacogenomics And Functional Gene Testing
Table 7. Global Premarital Genetic Testing Market Size Growth Rate by Technical Methods (US$ Million): 2021 vs 2025 vs 2032
Table 8. Key Players of Gene Sequencing Testing
Table 9. Key Players of Microarray Testing
Table 10. Key Players of Karyotype Analysis
Table 11. Key Players of PCR Site-Directed Mutagenesis Detection
Table 12. Key Players of Multi-Technology Combined Testing Solutions
Table 13. Global Premarital Genetic Testing Market Size Growth Rate by Service Provider (US$ Million): 2021 vs 2025 vs 2032
Table 14. Key Players of Medical Institution Testing Services
Table 15. Key Players of Third-Party Genetic Testing Laboratory Services
Table 16. Key Players of DTC Genetic Testing Services
Table 17. Key Players of Integrated Medical + Genetic Counseling Services
Table 18. Global Premarital Genetic Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Premarital Genetic Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 20. Global Premarital Genetic Testing Market Size by Region (US$ Million), 2021–2026
Table 21. Global Premarital Genetic Testing Market Share by Region (2021–2026)
Table 22. Global Premarital Genetic Testing Forecasted Market Size by Region (US$ Million), 2027–2032
Table 23. Global Premarital Genetic Testing Market Share by Region (2027–2032)
Table 24. Premarital Genetic Testing Market Trends
Table 25. Premarital Genetic Testing Market Drivers
Table 26. Premarital Genetic Testing Market Challenges
Table 27. Premarital Genetic Testing Market Restraints
Table 28. Global Premarital Genetic Testing Revenue by Players (US$ Million), 2021–2026
Table 29. Global Premarital Genetic Testing Market Share by Players (2021–2026)
Table 30. Global Top Premarital Genetic Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on Premarital Genetic Testing Revenue, 2025
Table 31. Ranking of Global Top Premarital Genetic Testing Companies by Revenue (US$ Million) in 2025
Table 32. Global 5 Largest Players Market Share by Premarital Genetic Testing Revenue (CR5 and HHI), 2021–2026
Table 33. Global Key Players of Premarital Genetic Testing, Headquarters and Area Served
Table 34. Global Key Players of Premarital Genetic Testing, Products and Applications
Table 35. Global Key Players of Premarital Genetic Testing, Date of General Availability (GA)
Table 36. Mergers and Acquisitions, Expansion Plans
Table 37. Global Premarital Genetic Testing Market Size by Testing Content (US$ Million), 2021–2026
Table 38. Global Premarital Genetic Testing Revenue Market Share by Testing Content (2021–2026)
Table 39. Global Premarital Genetic Testing Forecasted Market Size by Testing Content (US$ Million), 2027–2032
Table 40. Global Premarital Genetic Testing Revenue Market Share by Testing Content (2027–2032)
Table 41. Global Premarital Genetic Testing Market Size by Application (US$ Million), 2021–2026
Table 42. Global Premarital Genetic Testing Revenue Market Share by Application (2021–2026)
Table 43. Global Premarital Genetic Testing Forecasted Market Size by Application (US$ Million), 2027–2032
Table 44. Global Premarital Genetic Testing Revenue Market Share by Application (2027–2032)
Table 45. North America Premarital Genetic Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. North America Premarital Genetic Testing Market Size by Country (US$ Million), 2021–2026
Table 47. North America Premarital Genetic Testing Market Size by Country (US$ Million), 2027–2032
Table 48. Europe Premarital Genetic Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 49. Europe Premarital Genetic Testing Market Size by Country (US$ Million), 2021–2026
Table 50. Europe Premarital Genetic Testing Market Size by Country (US$ Million), 2027–2032
Table 51. Asia-Pacific Premarital Genetic Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 52. Asia-Pacific Premarital Genetic Testing Market Size by Region (US$ Million), 2021–2026
Table 53. Asia-Pacific Premarital Genetic Testing Market Size by Region (US$ Million), 2027–2032
Table 54. Latin America Premarital Genetic Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 55. Latin America Premarital Genetic Testing Market Size by Country (US$ Million), 2021–2026
Table 56. Latin America Premarital Genetic Testing Market Size by Country (US$ Million), 2027–2032
Table 57. Middle East & Africa Premarital Genetic Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 58. Middle East & Africa Premarital Genetic Testing Market Size by Country (US$ Million), 2021–2026
Table 59. Middle East & Africa Premarital Genetic Testing Market Size by Country (US$ Million), 2027–2032
Table 60. NxGen MDx, LLC Company Details
Table 61. NxGen MDx, LLC Business Overview
Table 62. NxGen MDx, LLC Premarital Genetic Testing Product
Table 63. NxGen MDx, LLC Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 64. NxGen MDx, LLC Recent Development
Table 65. OPKO Health Company Details
Table 66. OPKO Health Business Overview
Table 67. OPKO Health Premarital Genetic Testing Product
Table 68. OPKO Health Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 69. OPKO Health Recent Development
Table 70. Gene by Gene Company Details
Table 71. Gene by Gene Business Overview
Table 72. Gene by Gene Premarital Genetic Testing Product
Table 73. Gene by Gene Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 74. Gene by Gene Recent Development
Table 75. Sonic Genetics Company Details
Table 76. Sonic Genetics Business Overview
Table 77. Sonic Genetics Premarital Genetic Testing Product
Table 78. Sonic Genetics Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 79. Sonic Genetics Recent Development
Table 80. MedGenome Labs Company Details
Table 81. MedGenome Labs Business Overview
Table 82. MedGenome Labs Premarital Genetic Testing Product
Table 83. MedGenome Labs Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 84. MedGenome Labs Recent Development
Table 85. Centogene Company Details
Table 86. Centogene Business Overview
Table 87. Centogene Premarital Genetic Testing Product
Table 88. Centogene Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 89. Centogene Recent Development
Table 90. LSI Medience Company Details
Table 91. LSI Medience Business Overview
Table 92. LSI Medience Premarital Genetic Testing Product
Table 93. LSI Medience Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 94. LSI Medience Recent Development
Table 95. GC Genome Company Details
Table 96. GC Genome Business Overview
Table 97. GC Genome Premarital Genetic Testing Product
Table 98. GC Genome Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 99. GC Genome Recent Development
Table 100. Illumina Company Details
Table 101. Illumina Business Overview
Table 102. Illumina Premarital Genetic Testing Product
Table 103. Illumina Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 104. Illumina Recent Development
Table 105. Fulgent Genetics Company Details
Table 106. Fulgent Genetics Business Overview
Table 107. Fulgent Genetics Premarital Genetic Testing Product
Table 108. Fulgent Genetics Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 109. Fulgent Genetics Recent Development
Table 110. Natera Company Details
Table 111. Natera Business Overview
Table 112. Natera Premarital Genetic Testing Product
Table 113. Natera Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 114. Natera Recent Development
Table 115. Clinical Labs Company Details
Table 116. Clinical Labs Business Overview
Table 117. Clinical Labs Premarital Genetic Testing Product
Table 118. Clinical Labs Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 119. Clinical Labs Recent Development
Table 120. Eurofins Scientific Company Details
Table 121. Eurofins Scientific Business Overview
Table 122. Eurofins Scientific Premarital Genetic Testing Product
Table 123. Eurofins Scientific Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 124. Eurofins Scientific Recent Development
Table 125. Myriad Genetics Company Details
Table 126. Myriad Genetics Business Overview
Table 127. Myriad Genetics Premarital Genetic Testing Product
Table 128. Myriad Genetics Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 129. Myriad Genetics Recent Development
Table 130. Thermo Fisher Scientific Company Details
Table 131. Thermo Fisher Scientific Business Overview
Table 132. Thermo Fisher Scientific Premarital Genetic Testing Product
Table 133. Thermo Fisher Scientific Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 134. Thermo Fisher Scientific Recent Development
Table 135. Genoma Group Company Details
Table 136. Genoma Group Business Overview
Table 137. Genoma Group Premarital Genetic Testing Product
Table 138. Genoma Group Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 139. Genoma Group Recent Development
Table 140. SRL Inc. Company Details
Table 141. SRL Inc. Business Overview
Table 142. SRL Inc. Premarital Genetic Testing Product
Table 143. SRL Inc. Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 144. SRL Inc. Recent Development
Table 145. Seegene Company Details
Table 146. Seegene Business Overview
Table 147. Seegene Premarital Genetic Testing Product
Table 148. Seegene Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 149. Seegene Recent Development
Table 150. Huizhi Gene Company Details
Table 151. Huizhi Gene Business Overview
Table 152. Huizhi Gene Premarital Genetic Testing Product
Table 153. Huizhi Gene Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 154. Huizhi Gene Recent Development
Table 155. My Baby Company Company Details
Table 156. My Baby Company Business Overview
Table 157. My Baby Company Premarital Genetic Testing Product
Table 158. My Baby Company Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 159. My Baby Company Recent Development
Table 160. Invitae Company Details
Table 161. Invitae Business Overview
Table 162. Invitae Premarital Genetic Testing Product
Table 163. Invitae Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 164. Invitae Recent Development
Table 165. Dian Diagnostics Group Company Details
Table 166. Dian Diagnostics Group Business Overview
Table 167. Dian Diagnostics Group Premarital Genetic Testing Product
Table 168. Dian Diagnostics Group Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 169. Dian Diagnostics Group Recent Development
Table 170. Adicon Company Details
Table 171. Adicon Business Overview
Table 172. Adicon Premarital Genetic Testing Product
Table 173. Adicon Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 174. Adicon Recent Development
Table 175. BGI Company Details
Table 176. BGI Business Overview
Table 177. BGI Premarital Genetic Testing Product
Table 178. BGI Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 179. BGI Recent Development
Table 180. WuXi AppTec Company Details
Table 181. WuXi AppTec Business Overview
Table 182. WuXi AppTec Premarital Genetic Testing Product
Table 183. WuXi AppTec Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 184. WuXi AppTec Recent Development
Table 185. Novogene Company Details
Table 186. Novogene Business Overview
Table 187. Novogene Premarital Genetic Testing Product
Table 188. Novogene Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 189. Novogene Recent Development
Table 190. Berry Genomics Company Details
Table 191. Berry Genomics Business Overview
Table 192. Berry Genomics Premarital Genetic Testing Product
Table 193. Berry Genomics Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 194. Berry Genomics Recent Development
Table 195. Kingmed Diagnostic Company Details
Table 196. Kingmed Diagnostic Business Overview
Table 197. Kingmed Diagnostic Premarital Genetic Testing Product
Table 198. Kingmed Diagnostic Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 199. Kingmed Diagnostic Recent Development
Table 200. Zhongyuan Concord Company Details
Table 201. Zhongyuan Concord Business Overview
Table 202. Zhongyuan Concord Premarital Genetic Testing Product
Table 203. Zhongyuan Concord Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 204. Zhongyuan Concord Recent Development
Table 205. AmoyDx Company Details
Table 206. AmoyDx Business Overview
Table 207. AmoyDx Premarital Genetic Testing Product
Table 208. AmoyDx Revenue in Premarital Genetic Testing Business (US$ Million), 2021–2026
Table 209. AmoyDx Recent Development
Table 210. Research Programs/Design for This Report
Table 211. Key Data Information from Secondary Sources
Table 212. Key Data Information from Primary Sources
Table 213. Authors List of This Report
List of Figures
Figure 1. Premarital Genetic Testing Picture
Figure 2. Global Premarital Genetic Testing Market Size Comparison by Testing Content (US$ Million), 2021–2032
Figure 3. Global Premarital Genetic Testing Market Share by Testing Content: 2025 vs 2032
Figure 4. Single-Gene Genetic Disease Testing Features
Figure 5. Chromosomal Structural And Numerical Abnormality Testing Features
Figure 6. Polygenic Disease Risk Assessment Features
Figure 7. Mitochondrial And Maternal Genetic Testing Features
Figure 8. Pharmacogenomics And Functional Gene Testing Features
Figure 9. Global Premarital Genetic Testing Market Size Comparison by Technical Methods (US$ Million), 2021–2032
Figure 10. Gene Sequencing Testing Features
Figure 11. Microarray Testing Features
Figure 12. Karyotype Analysis Features
Figure 13. PCR Site-Directed Mutagenesis Detection Features
Figure 14. Multi-Technology Combined Testing Solutions Features
Figure 15. Global Premarital Genetic Testing Market Size Comparison by Service Provider (US$ Million), 2021–2032
Figure 16. Medical Institution Testing Services Features
Figure 17. Third-Party Genetic Testing Laboratory Services Features
Figure 18. DTC Genetic Testing Services Features
Figure 19. Integrated Medical + Genetic Counseling Services Features
Figure 20. Global Premarital Genetic Testing Market Size by Application (US$ Million), 2021–2032
Figure 21. Global Premarital Genetic Testing Market Share by Application: 2025 vs 2032
Figure 22. Male Case Studies
Figure 23. Female Case Studies
Figure 24. Premarital Genetic Testing Report Years Considered
Figure 25. Global Premarital Genetic Testing Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 26. Global Premarital Genetic Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 27. Global Premarital Genetic Testing Market Share by Region: 2025 vs 2032
Figure 28. Global Premarital Genetic Testing Market Share by Players in 2025
Figure 29. Global Premarital Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 30. The Top 10 and 5 Players Market Share by Premarital Genetic Testing Revenue in 2025
Figure 31. North America Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. North America Premarital Genetic Testing Market Share by Country (2021–2032)
Figure 33. United States Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Canada Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Europe Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Europe Premarital Genetic Testing Market Share by Country (2021–2032)
Figure 37. Germany Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. France Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. U.K. Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Italy Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Russia Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Ireland Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Asia-Pacific Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Asia-Pacific Premarital Genetic Testing Market Share by Region (2021–2032)
Figure 45. China Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Japan Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. South Korea Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Southeast Asia Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. India Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Australia & New Zealand Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Latin America Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Latin America Premarital Genetic Testing Market Share by Country (2021–2032)
Figure 53. Mexico Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Brazil Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Middle East & Africa Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Middle East & Africa Premarital Genetic Testing Market Share by Country (2021–2032)
Figure 57. Israel Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 58. Saudi Arabia Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 59. UAE Premarital Genetic Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 60. NxGen MDx, LLC Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 61. OPKO Health Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 62. Gene by Gene Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 63. Sonic Genetics Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 64. MedGenome Labs Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 65. Centogene Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 66. LSI Medience Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 67. GC Genome Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 68. Illumina Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 69. Fulgent Genetics Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 70. Natera Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 71. Clinical Labs Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 72. Eurofins Scientific Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 73. Myriad Genetics Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 74. Thermo Fisher Scientific Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 75. Genoma Group Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 76. SRL Inc. Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 77. Seegene Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 78. Huizhi Gene Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 79. My Baby Company Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 80. Invitae Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 81. Dian Diagnostics Group Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 82. Adicon Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 83. BGI Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 84. WuXi AppTec Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 85. Novogene Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 86. Berry Genomics Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 87. Kingmed Diagnostic Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 88. Zhongyuan Concord Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 89. AmoyDx Revenue Growth Rate in Premarital Genetic Testing Business (2021–2026)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed